January 12, 2018
A New Jersey federal judge on Friday refused to dismiss the bulk of claims lodged in two sets of securities suits against Valeant Pharmaceuticals International Inc., ruling, among other things, that investors' allegations of fraud and other violations met specificity requirements of the relevant laws.
July 31, 2017
T. Rowe Price Group Inc. and other investors asked a New Jersey federal court on Friday not to dismiss their securities suits against Valeant Pharmaceuticals International Inc., saying Valeant and its executives have rehashed the same arguments that the court rejected in a similar case.